Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Clinical Trials Search

As a clinical trial candidate at Methodist, you’re offered unique access to new drugs and technology being studied to improve patient outcomes.
Filter by Disease or Condition
Showing 61-63 results of 63
Lung Cancer

SWOG / S2302

Official Title: Non-chemotherapy treatment (Ramucirumab plus Pembrolizumab) or usual care for advanced non-small cell lung cancer following immunotherapy
Study Purpose: To compare overall survival in participants previously treated with platinum-based chemotherapy and immunotherapy for stage IV or recurrent non-small cell lung cancer randomized to Pembrolizumab and Ramucirumab versus standard of care. 
Status: Recruiting
Lung Cancer

Xencor / XmAb717-06

Official Title: Aphase 1b/2 Open Label, Randomized Study of Vudalimab in Combination With Chemotherapy or Pembrolizumab In Combination With Chemotherapy as First Line Treatment In Patients with Advanced Non-Small Lung Cancer 
Study Purpose: To find a safe, tolerable, and recommended dose of vudalimab for people with locally advanced (unresectable) or metastatic NSCL when combine with chemotherapy.
Status: Recruiting
Gynecologic Cancer

Zentalis / ZN-c3-005

Official Title: A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN‑c3 (Azenosertib) in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer 
Study Purpose: To evaluate the safety, clinical activity, and pharmacokinetics of ZN-c3 (also known as azenosertib) in subjects with platinum-resistant, high-grade serous ovarian, fallopian tube, or primary peritoneal cancer 
Status: Suspended